{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:45:00Z","timestamp":1767833100686,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1208\/s12249-022-02254-4","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T21:02:48Z","timestamp":1649710968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Albumin-Embellished Arsenic Trioxide-Loaded Polymeric Nanoparticles Enhance Tumor Accumulation and Anticancer Efficacy via Transcytosis for Hepatocellular Carcinoma Therapy"],"prefix":"10.1208","volume":"23","author":[{"given":"Yu","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhishi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunping","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"issue":"5","key":"2254_CR1","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1182\/blood-2007-07-102798","volume":"111","author":"ZY Wang","year":"2008","unstructured":"Wang ZY, Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood. 2008;111(5):2505\u201315. https:\/\/doi.org\/10.1182\/blood-2007-07-102798.","journal-title":"Blood."},{"issue":"5","key":"2254_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/2040620711410773","volume":"2","author":"J Park","year":"2011","unstructured":"Park J, Jurcic JG, Rosenblat T, Tallman MS. Emerging new approaches for the treatment of acute promyelocytic leukemia. Ther Adv Hematol. 2011;2(5):335\u201352. https:\/\/doi.org\/10.1177\/2040620711410773.","journal-title":"Ther Adv Hematol"},{"key":"2254_CR3","doi-asserted-by":"publisher","first-page":"119385","DOI":"10.1016\/j.ijpharm.2020.119385","volume":"583","author":"W Fei","year":"2020","unstructured":"Fei W, Li C, Tao J, Cai X, Yao W, Ye Y, Zhang Y, Yao Y, Song Q, Li F, Zheng C. Construction of arsenic-metal complexes loaded nanodrugs for solid tumor therapy: A mini review. Int J Pharm. 2020;583:119385. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119385.","journal-title":"Int J Pharm"},{"issue":"3","key":"2254_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7555\/jbr.31.20160059","volume":"31","author":"A Akhtar","year":"2017","unstructured":"Akhtar A, Wang SX, Ghali L, Bell C, Wen X. Recent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancers. J Biomed Res. 2017;31(3):177\u201388. https:\/\/doi.org\/10.7555\/jbr.31.20160059.","journal-title":"J Biomed Res"},{"issue":"6","key":"2254_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3892\/etm.2020.9299","volume":"20","author":"L Zhang","year":"2020","unstructured":"Zhang L, Zhou Y, Kong J, Zhang L, Yuan M, Xian S, Wang Y, Cheng Y, Yang X. Effect of arsenic trioxide on cervical cancer and its mechanisms. Exp Ther Med. 2020;20(6):169\u201372. https:\/\/doi.org\/10.3892\/etm.2020.9299.","journal-title":"Exp Ther Med"},{"issue":"2","key":"2254_CR6","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1021\/acs.molpharmaceut.8b01056","volume":"16","author":"J Tao","year":"2019","unstructured":"Tao J, Fei W, Tang H, Li C, Mu C, Zheng H, Li F, Zhu Z. Angiopep-2-Conjugated \"Core-Shell\" Hybrid Nanovehicles for Targeted and pH-Triggered Delivery of Arsenic Trioxide into Glioma. Mol Pharm. 2019;16(2):786\u201397. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b01056.","journal-title":"Mol Pharm"},{"key":"2254_CR7","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.2147\/ijn.S175418","volume":"13","author":"Y Lu","year":"2018","unstructured":"Lu Y, Han S, Zheng H, Ma R, Ping Y, Zou J, Tang H, Zhang Y, Xu X, Li F. A novel RGDyC\/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system. Int J Nanomedicine. 2018;13:5937\u201352. https:\/\/doi.org\/10.2147\/ijn.S175418.","journal-title":"Int J Nanomedicine"},{"issue":"1-2","key":"2254_CR8","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ijpharm.2017.01.031","volume":"519","author":"W Fei","year":"2017","unstructured":"Fei W, Zhang Y, Han S, Tao J, Zheng H, Wei Y, Zhu J, Li F, Wang X. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma. Int J Pharm. 2017;519(1-2):250\u201362. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.01.031.","journal-title":"Int J Pharm"},{"issue":"1","key":"2254_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1476-4598-13-133","volume":"13","author":"T Zheng","year":"2014","unstructured":"Zheng T, Yin D, Lu Z, Wang J, Li Y, Chen X, Liang Y, Song X, Qi S, Sun B, Xie C, Meng X, Pan S, Liu J, Jiang H, Liu L. Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma. Mol Cancer. 2014;13(1):133. https:\/\/doi.org\/10.1186\/1476-4598-13-133.","journal-title":"Mol Cancer"},{"key":"2254_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jphotobiol.2015.03.001","volume":"148","author":"S Shooshtary","year":"2015","unstructured":"Shooshtary S, Behtash S, Nafisi S. Arsenic trioxide binding to serum proteins. J Photochem Photobiol B Biol. 2015;148:31\u20136. https:\/\/doi.org\/10.1016\/j.jphotobiol.2015.03.001.","journal-title":"J Photochem Photobiol B Biol"},{"issue":"21","key":"2254_CR11","doi-asserted-by":"publisher","first-page":"12292","DOI":"10.1021\/ic401211u","volume":"52","author":"EP Swindell","year":"2013","unstructured":"Swindell EP, Hankins PL, Chen H, Miodragovic DU, O'Halloran TV. Anticancer Activity of Small-Molecule and Nanoparticulate Arsenic(III) Complexes. Inorg Chem. 2013;52(21):12292\u2013304. https:\/\/doi.org\/10.1021\/ic401211u.","journal-title":"Inorg Chem"},{"issue":"2","key":"2254_CR12","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s40242-014-3306-9","volume":"30","author":"X Song","year":"2014","unstructured":"Song X, You J, Wang J, Zhu A, Ji L, Guo R. Preparation and Investigation of Arsenic Trioxide-loaded Polylactic Acid\/Magnetic Hybrid Nanoparticles. Chem Res Chin Univ. 2014;30(2):326\u201332. https:\/\/doi.org\/10.1007\/s40242-014-3306-9.","journal-title":"Chem Res Chin Univ"},{"issue":"1","key":"2254_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","volume":"17","author":"J Shi","year":"2017","unstructured":"Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17(1):20\u201337. https:\/\/doi.org\/10.1038\/nrc.2016.108.","journal-title":"Nat Rev Cancer"},{"key":"2254_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.addr.2016.04.025","volume":"108","author":"JI Hare","year":"2017","unstructured":"Hare JI, Lammers T, Ashford MB, Puri S, Storm G, Barry ST. Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. Adv Drug Deliv Rev. 2017;108:25\u201338. https:\/\/doi.org\/10.1016\/j.addr.2016.04.025.","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"2254_CR15","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.2217\/nnm-2018-0347","volume":"14","author":"L He","year":"2019","unstructured":"He L, Liu Y, Lau J, Fan W, Li Q, Zhang C, Huang P, Chen X. Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapy. Nanomedicine. 2019;14(10):1343\u201365. https:\/\/doi.org\/10.2217\/nnm-2018-0347.","journal-title":"Nanomedicine."},{"issue":"3","key":"2254_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00775-018-1537-9","volume":"23","author":"M Hoonjan","year":"2018","unstructured":"Hoonjan M, Jadhav V, Bhatt P. Arsenic trioxide: insights into its evolution to an anticancer agent. J Biol Inorg Chem. 2018;23(3):313\u201329. https:\/\/doi.org\/10.1007\/s00775-018-1537-9.","journal-title":"J Biol Inorg Chem"},{"issue":"1","key":"2254_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1177\/0885328216637211","volume":"31","author":"X Xiao","year":"2016","unstructured":"Xiao X, Liu Y, Guo M, Fei W, Zheng H, Zhang R, Zhang Y, Wei Y, Zheng G, Li F. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo. J Biomater Appl. 2016;31(1):23\u201335. https:\/\/doi.org\/10.1177\/0885328216637211.","journal-title":"J Biomater Appl"},{"issue":"9","key":"2254_CR18","doi-asserted-by":"publisher","first-page":"1604634","DOI":"10.1002\/adma.201604634","volume":"29","author":"JG Croissant","year":"2017","unstructured":"Croissant JG, Fatieiev Y, Khashab NM. Degradability and Clearance of Silicon, Organosilica, Silsesquioxane, Silica Mixed Oxide, and Mesoporous Silica Nanoparticles. Adv Mater. 2017;29(9):1604634. https:\/\/doi.org\/10.1002\/adma.201604634.","journal-title":"Adv Mater"},{"issue":"23","key":"2254_CR19","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1002\/smll.200900923","volume":"5","author":"Q He","year":"2009","unstructured":"He Q, Zhang Z, Gao Y, Shi J, Li Y. Intracellular Localization and Cytotoxicity of Spherical Mesoporous Silica Nano- and Microparticles. Small. 2009;5(23):2722\u20139. https:\/\/doi.org\/10.1002\/smll.200900923.","journal-title":"Small."},{"issue":"19","key":"2254_CR20","doi-asserted-by":"publisher","first-page":"11043","DOI":"10.1021\/cr5006793","volume":"115","author":"U Laechelt","year":"2015","unstructured":"Laechelt U, Wagner E. Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond). Chem Rev. 2015;115(19):11043\u201378. https:\/\/doi.org\/10.1021\/cr5006793.","journal-title":"Chem Rev"},{"key":"2254_CR21","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.2147\/ijn.S166445","volume":"13","author":"D Chen","year":"2018","unstructured":"Chen D, Han S, Zhu Y, Hu F, Wei Y, Wang G. Kidney-targeted drug delivery via rhein-loaded polyethyleneglycol-co-polycaprolactone-co-polyethylenimine nanoparticles for diabetic nephropathy therapy. Int J Nanomedicine. 2018;13:3507\u201327. https:\/\/doi.org\/10.2147\/ijn.S166445.","journal-title":"Int J Nanomedicine"},{"key":"2254_CR22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.omto.2021.07.013","volume":"22","author":"R Robb","year":"2021","unstructured":"Robb R, Kuo JC-T, Liu Y, Corrales-Guerrero S, Cui T, Hegazi A, Nagy G, Lee RJ, Williams TM. A novel protein-drug conjugate, SSH20, demonstrates significant efficacy in caveolin-1-expressing tumors. Mol Ther-Oncol. 2021;22:555\u201364. https:\/\/doi.org\/10.1016\/j.omto.2021.07.013.","journal-title":"Mol Ther-Oncol"},{"key":"2254_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.addr.2018.07.011","volume":"130","author":"EN Hoogenboezem","year":"2018","unstructured":"Hoogenboezem EN, Duvall CL. Harnessing albumin as a carrier for cancer therapies. Adv Drug Deliv Rev. 2018;130:73\u201389. https:\/\/doi.org\/10.1016\/j.addr.2018.07.011.","journal-title":"Adv Drug Deliv Rev"},{"issue":"17","key":"2254_CR24","doi-asserted-by":"publisher","first-page":"19736","DOI":"10.1021\/acsami.1c03065","volume":"13","author":"M Hama","year":"2021","unstructured":"Hama M, Ishima Y, Chuang VTG, Ando H, Shimizu T, Ishida T. Evidence for Delivery of Abraxane via a Denatured-Albumin Transport System. ACS Appl Mater Interfaces. 2021;13(17):19736\u201344. https:\/\/doi.org\/10.1021\/acsami.1c03065.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"2254_CR25","doi-asserted-by":"publisher","first-page":"4890","DOI":"10.1021\/acsnano.0c00974","volume":"14","author":"G Wang","year":"2020","unstructured":"Wang G, Zhou Z, Zhao Z, Li Q, Wu Y, Yan S, Shen Y, Huang P. Enzyme-Triggered Transcytosis of Dendrimer-Drug Conjugate for Deep Penetration into Pancreatic Tumors. ACS Nano. 2020;14(4):4890\u2013904. https:\/\/doi.org\/10.1021\/acsnano.0c00974.","journal-title":"ACS Nano"},{"issue":"1","key":"2254_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cclet.2020.11.029","volume":"32","author":"X Zheng","year":"2020","unstructured":"Zheng X, Xie J, Zhang X, Sun W, Zhao H, Li Y, Wang C. An overview of polymeric nanomicelles in clinical trials and on the market. Chin Chem Lett. 2020;32(1):243\u201357. https:\/\/doi.org\/10.1016\/j.cclet.2020.11.029.","journal-title":"Chin Chem Lett"},{"issue":"6","key":"2254_CR27","doi-asserted-by":"publisher","first-page":"6179","DOI":"10.1021\/acsnano.8b02830","volume":"12","author":"XR Sun","year":"2018","unstructured":"Sun XR, Wang GW, Zhang H, Hu SQ, Liu X, Tang JB, Shen YQ. The Blood Clearance Kinetics and Pathway of Polymeric Micelles in Cancer Drug Delivery. ACS Nano. 2018;12(6):6179\u201392. https:\/\/doi.org\/10.1021\/acsnano.8b02830.","journal-title":"ACS Nano"},{"issue":"14","key":"2254_CR28","doi-asserted-by":"publisher","first-page":"1606628","DOI":"10.1002\/adma.201606628","volume":"29","author":"Q Sun","year":"2017","unstructured":"Sun Q, Zhou Z, Qiu N, Shen Y. Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization. Adv Mater. 2017;29(14):1606628. https:\/\/doi.org\/10.1002\/adma.201606628.","journal-title":"Adv Mater"},{"issue":"2","key":"2254_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.nantod.2016.04.008","volume":"11","author":"HX Wang","year":"2016","unstructured":"Wang HX, Zuo ZQ, Du JZ, Wang YC, Sun R, Cao ZT, Ye XD, Wang JL, Leong KW, Wang J. Surface charge critically affects tumor penetration and therapeutic efficacy of cancer nanomedicines. Nano Today. 2016;11(2):133\u201344. https:\/\/doi.org\/10.1016\/j.nantod.2016.04.008.","journal-title":"Nano Today"},{"key":"2254_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cis.2015.10.011","volume":"228","author":"M Manaargadoo-Catin","year":"2016","unstructured":"Manaargadoo-Catin M, Ali-Cherif A, Pougnas J-L, Perrin C. Hemolysis by surfactants-A review. Adv Colloid Interf Sci. 2016;228:1\u201316. https:\/\/doi.org\/10.1016\/j.cis.2015.10.011.","journal-title":"Adv Colloid Interf Sci"},{"issue":"11","key":"2254_CR31","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/nmat4718","volume":"15","author":"KM Tsoi","year":"2016","unstructured":"Tsoi KM, MacParland SA, Ma X-Z, Spetzler VN, Echeverri J, Ouyang B, Fadel SM, Sykes EA, Goldaracena N, Kaths JM, Conneely JB, Alman BA, Selzner M, Ostrowski MA, Adeyi OA, Zilman A, McGilvray ID, Chan WCW. Mechanism of hard-nanomaterial clearance by the liver. Nat Mater. 2016;15(11):1212\u201321. https:\/\/doi.org\/10.1038\/nmat4718.","journal-title":"Nat Mater"},{"key":"2254_CR32","doi-asserted-by":"publisher","first-page":"2004172","DOI":"10.1002\/smll.202004172","volume":"16","author":"G Wang","year":"2020","unstructured":"Wang G, Bihan W, Li Q, Chen S, Jin X, Liu Y, Zhou Z, Shen Y, Huang P. Active transportation of liposome enhances tumor accumulation, penetration, and therapeutic efficacy. Small. 2020;16:2004172. https:\/\/doi.org\/10.1002\/smll.202004172.","journal-title":"Small."},{"key":"2254_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3109\/08982104.2010.483597","volume":"21","author":"N Winter","year":"2011","unstructured":"Winter N, Murphy RJ, o Halloran T, Schatz G. Development and modeling of arsenic-trioxide loaded thermosensitive liposomes for anticancer drug delivery. Journal of Liposome. Research. 2011;21:106\u201315. https:\/\/doi.org\/10.3109\/08982104.2010.483597.","journal-title":"Research."},{"key":"2254_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.biomaterials.2016.01.061","volume":"85","author":"M Kanamala","year":"2016","unstructured":"Kanamala M, Wilson WR, Yang M, Palmer BD, Wu Z. Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review. Biomaterials. 2016;85:152\u201367. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.01.061.","journal-title":"Biomaterials."},{"issue":"25","key":"2254_CR35","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.1016\/j.biomaterials.2014.04.072","volume":"35","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Vakili MR, Li X-F, Lavasanifar A, Le XC. Polymeric micelles for GSH-triggered delivery of arsenic species to cancer cells. Biomaterials. 2014;35(25):7088\u2013100. https:\/\/doi.org\/10.1016\/j.biomaterials.2014.04.072.","journal-title":"Biomaterials."},{"issue":"14","key":"2254_CR36","first-page":"3893","volume":"62","author":"WH Miller","year":"2002","unstructured":"Miller WH, Schipper HM, Lee JS, Singer J, Waxman S. Mechanisms of action of arsenic trioxide. Cancer Res. 2002;62(14):3893\u2013903.","journal-title":"Cancer Res"},{"issue":"11","key":"2254_CR37","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nmat3776","volume":"12","author":"S Mura","year":"2013","unstructured":"Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013;12(11):991\u20131003. https:\/\/doi.org\/10.1038\/nmat3776.","journal-title":"Nat Mater"},{"issue":"4","key":"2254_CR38","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nnano.2015.330","volume":"11","author":"S Schoettler","year":"2016","unstructured":"Schoettler S, Becker G, Winzen S, Steinbach T, Mohr K, Landfester K, Mailaender V, Wurm FR. Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. Nat Nanotechnol. 2016;11(4):372\u20137. https:\/\/doi.org\/10.1038\/nnano.2015.330.","journal-title":"Nat Nanotechnol"},{"issue":"11","key":"2254_CR39","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1021\/acs.molpharmaceut.8b00612","volume":"15","author":"G Su","year":"2018","unstructured":"Su G, Jiang H, Xu B, Yu Y, Chen X. Effects of Protein Corona on Active and Passive Targeting of Cyclic RGD Peptide-Functionalized PEGylation Nanoparticles. Mol Pharm. 2018;15(11):5019\u201330. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00612.","journal-title":"Mol Pharm"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02254-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-022-02254-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-022-02254-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T13:16:05Z","timestamp":1650892565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-022-02254-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["2254"],"URL":"https:\/\/doi.org\/10.1208\/s12249-022-02254-4","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,11]]},"assertion":[{"value":"3 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"111"}}